Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2021

Nov 15, 2021

SELL
$110.2 - $156.64 $639,160 - $908,511
-5,800 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$100.84 - $161.89 $584,872 - $938,961
5,800 New
5,800 $939,000
Q1 2021

May 17, 2021

SELL
$110.72 - $210.04 $321,088 - $609,116
-2,900 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$79.67 - $173.23 $231,043 - $502,366
2,900 New
2,900 $444,000

Others Institutions Holding CRSP

About CRISPR Therapeutics AG


  • Ticker CRSP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,009,296
  • Market Cap $3.61B
  • Description
  • CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....
More about CRSP
Track This Portfolio

Track Css LLC Portfolio

Follow Css LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Css LLC, based on Form 13F filings with the SEC.

News

Stay updated on Css LLC with notifications on news.